| Outgoing Relation(s) |
| cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) is a cysteine protease inhibitor (CHEBI:64152) |
| cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) is a EC 3.4.22.* (cysteine endopeptidase) inhibitor (CHEBI:76796) |
| Incoming Relation(s) |
| diazepinomicin (CHEBI:156321) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| SID 26681509 (CHEBI:167893) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| TMC-52A (CHEBI:66238) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| TMC-52B (CHEBI:66239) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| TMC-52C (CHEBI:66240) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| TMC-52D (CHEBI:66241) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| WF14865A (CHEBI:66322) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| WF14865B (CHEBI:66323) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
| Z-Phe-Phe-CHN2 (CHEBI:10098) has role cathepsin L (EC 3.4.22.15) inhibitor (CHEBI:70821) |
